Renew X Pharma Launches Cutting-Edge Online Platform for Premium Wellness Products
Renew X Pharma Launches Cutting-Edge Online Platform for Premium Wellness Products
05 nov. 2024 15h35 HE | Renew X Pharma
Vancouver, Canada, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Renew X Pharma has launched a new website, offering a user-friendly platform for individuals seeking reliable wellness products. From...
E-star+Social.jpg
E-Star BioTech Set to Initiate Phase 2 Clinical Trial of MANP in Resistant Hypertension With Support of Latest Investment
08 oct. 2024 09h00 HE | E-Star Biotech
NEW YORK, Oct. 08, 2024 (GLOBE NEWSWIRE) -- E-Star BioTech, LLC (“E-Star” or the “Company”), an innovative developer of novel peptides designed to treat cardiovascular, metabolic, and kidney...
1ProLynx LOGO.png
ProLynx announces preclinical results of long-acting semaglutide requiring once monthly dosing
21 août 2024 14h16 HE | ProLynx Inc.
SAN FRANCISCO, Aug. 21, 2024 (GLOBE NEWSWIRE) -- ProLynx Inc. today announced the use of their technology to create a long-acting semaglutide that can be administered once monthly. The ProLynx...
wholisticresearch-logo.png
WholisticResearch Announces Launch of AI-Based Nootropics Research Assistant NootsAI™
19 juil. 2024 09h00 HE | WholisticResearch
Eastbourne, England, July 19, 2024 (GLOBE NEWSWIRE) -- WholisticResearch, a highly respected developer and researcher of cutting-edge nootropics, peptides, and supplements that optimize cognitive...
limitless-biotech-logo.png
Best Peptides Company of 2024 Announced As Limitless Biotech
29 mai 2024 09h00 HE | Limitless Biotech
Gulf Breeze, FL, May 29, 2024 (GLOBE NEWSWIRE) -- Limitless Biotech, a leading provider of high-quality peptides, proudly announces its ascension as the best peptide company in the industry. Through...
website-logo (2).png
Peptides Market Projected to Exceed US$ 89.6 Bn by 2033 Driven by Advancement in Peptide Synthesis | Marketresearch.biz
29 janv. 2024 02h03 HE | MarketResearch.biz
New York, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The peptides market was valued at USD 45.5 billion in 2023 with significant growth and is projected to reach at USD 89.6 billion by 2033 with an...
Telegenixx.png
Workplace Weight Loss & Wellness Program Unveiled
04 oct. 2023 13h27 HE | Telegenixx
Telegenix's New Program Enables Employers to Provide Access to Pharma-Assisted Weight Loss at a Cost of $299 per Month, 70% Below the Industry Average
HBC_Logo2020_RGB.png
Hofseth Biocare ASA: SUCCESSFULLY COMPLETED SEED ROUND CAPITAL RAISE IN HBC IMMUNOLOGY LLC AT $20M VALUATION FOR THE DEVELOPMENT OF A NEW PROSTATE CANCER CO-THERAPY
17 août 2023 02h58 HE | Hofseth Biocare ASA
HBC Immunology LLC (“HBCI” or the “Company”), a majority owned subsidiary of Hofseth BioCare ASA (“HBC”), has successfully completed the required minimum seed capital financing of approx. USD 900,000...
Growing Emphasis on Generic Drug Manufacturing Boosts Active Pharmaceutical Ingredient Market to US$ 300.2 Billion by 2033: Persistence Market Research
25 juil. 2023 14h33 HE | Persistence Market Research
New York, July 25, 2023 (GLOBE NEWSWIRE) -- Worldwide revenue from the active pharmaceutical ingredients market stands at US$ 192.3 Billion in 2022, with the global market estimated to surge ahead...
TIP_link_300x300.jpg
Size Report: Cosmeceuticals Market to Reach $81.75 Billion by 2028 with Skin Care Segment Driving Growth during 2021-2028 | The Insight Partners
11 juil. 2023 09h46 HE | The Insight Partners
Pune, India, July 11, 2023 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Cosmeceuticals Market Size Report, Share, Revenue, Growth Strategy, Industry Trends and...